MIRA — Mira Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Mira Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2.81 | 0.351 | 4.6 | 2.83 | 11 |
| Net Total Receivables | — | — | 0.012 | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2.91 | 0.494 | 4.86 | 2.89 | 11.1 |
| Net Property, Plant And Equipment | — | 0.364 | 0.005 | 0 | — |
| Long Term Notes Receivable | |||||
| Total Assets | 3.36 | 0.858 | 4.93 | 2.92 | 11.1 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.09 | 1.37 | 0.558 | 0.723 | 0.702 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.09 | 1.45 | 0.558 | 0.723 | 0.702 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.26 | -0.596 | 4.37 | 2.2 | 10.4 |
| Total Liabilities & Shareholders' Equity | 3.36 | 0.858 | 4.93 | 2.92 | 11.1 |
| Total Common Shares Outstanding |